A name familiar to the medical device industry has surfaced as a possible nominee to lead the FDA: the Trump administration is reportedly mulling Dr. Joseph Gulfo, the former CEO of Mela Sciences (now Strata Skin Sciences (NSDQ:SSKN)), for FDA commissioner. Dr. Stephen Ostroff is leading the federal safety watchdog on an interim basis, after the resignation of […]
MELA Sciences Inc.
Mela Sciences, no more; Company rebrands as Strata Skin Science
Mela Sciences (NSDQ:MELA) said today it is changing its corporate name to Strata Skin Sciences, effective January 5 next year. The shift is being made to reflect the company’s focus on dermatology and a broad range of conditions, according to CEO Michael Stewart. “Our June 2015 Xtrac acquisition has expanded the dermatological opportunities that the […]
AliveCor taps Google social SVP Gundotra for CEO | Personnel Moves
AliveCor said yesterday it tagged former Google (NSDQ:GOOG) social senior veep Vic Gundotra as its new CEO, replacing current interim CEO Euan Thomson. Gundotra served as senior veep at Google from 2011 to 2014, after joining as a veep in 2007. Gundotra was responsible for Google’s social networking and identity services, and is credited as […]
EnteroMedics names ex-Lanx chief Gladney as CEO | Personnel Moves
EnteroMedics (NSDQ:ETRM) said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16. St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will […]
Mela Sciences buys Photomedex Xtrac, Vtrac assets
Mela Sciences (NSDQ:Mela) said today that it agreed to purchased PhotoMedex’s (NSDQ:PHMD) Xtrac and Vtrac laser business assets for $42.5 million. Xtrac and Vtrac are devices used to treat psoriasis, vitiligo and other skin diseases, the company said. “This is a transformational event for Mela Sciences. As a result of this acquisition, Mela becomes a multi-product […]
Mela Sciences recalls MelaFind
Mela Sciences (NSDQ:MELA) recalled its flagship MelaFind melanoma diagnosis aid because some of its software wasn’t included in its pre-market approval from the FDA.
More changes at Hologic as it axes administrative chief Casey | Personnel Moves
Press Release: MELA Sciences Begins Insurance Reimbursement Process With Application for New CPT Code for the MelaFind System
Mela Sciences seeks reimbursement for melanoma detector
CeQur names medtech veteran as new CEO | Medtech personnel moves for the week of Apr. 14, 2014
CeQur gets new CEO from Becton Dickinson | Personnel Moves
April 11, 2014 by Arezu Sarvestani
Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.
CeQur gets new CEO from Becton Dickinson | Personnel Moves
Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.
Lawrence has spent more than 25 years in the medical device industry, most recently as vice president of the insulin injection business at Becton, Dickinson’s (NYSE:BDX) diabetes arm.
